Cerus Corp. Stock, NASDAQ:CERS
1220 Concord Avenue, Suite 600, Concord, California 94520
United States of America
Number of Employees: 270
Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.